DBS of the ANT for refractory epilepsy: A single center experience of seizure reduction, side effects and neuropsychological outcomes

被引:7
|
作者
Dague, Karmele Olaciregui [1 ]
Witt, Juri-Alexander [1 ]
von Wrede, Randi [1 ]
Helmstaedter, Christoph [1 ]
Surges, Rainer [1 ]
机构
[1] Univ Hosp Bonn, Dept Epileptol, Bonn, Germany
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
deep brain stimulation; refractory epilepsy; cognition; side effects; neuropsychological assessment; DEEP BRAIN-STIMULATION; ANTERIOR THALAMIC NUCLEUS; ELECTRICAL-STIMULATION; TERM; INSIGHTS;
D O I
10.3389/fneur.2023.1106511
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveEvaluation of the antiseizure efficacy, side effects and neuropsychological effects of Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT). ANT-DBS is a treatment option for patients with difficult-to-treat epilepsy. Though several works outline the cognitive and/or mood effects of ANT-DBS for the treatment of epilepsy, data on the intersection between antiseizure efficacy, cognitive and undesired effects are scarce. MethodsWe retrospectively analyzed the data of our cohort of 13 patients. Post-implantation seizure frequencies were measured at 6 months, 12 months and last follow-up, as well as averaged throughout follow-up. These values were then compared with mean seizure frequencies in the 6 months before implantation. To address acute cognitive effects of DBS a baseline assessment was performed after implantation and before stimulation, and a follow-up assessment was conducted under DBS. The long-term effects of DBS on cognition were assessed by comparing the preoperative neuropsychological profile with a long-term follow-up under DBS. ResultsIn the entire cohort, 54.5% of patients were responders, with an average seizure reduction of 73.6%. One of these patients achieved temporary seizure freedom and near-total seizure reduction during the entire follow-up. Seizure reduction of <50% was achieved in 3 patients. Non-responders suffered an average seizure increase of 27.3%. Eight of twenty-two active electrodes (36,4%) were off-target. Two of our patients had both electrodes implanted off-target. When removing these two patients from the analysis and averaging seizure frequency during the entire follow-up period, four patients (44.4%) were responders and three experienced a seizure reduction of <50%. Intolerable side effects arose in 5 patients, mostly psychiatric. Regarding acute cognitive effects of DBS, only one patient showed a significant decline in executive functions. Long-term neuropsychological effects included significant intraindividual changes in verbal learning and memory. Figural memory, attention and executive functions, confrontative naming and mental rotation were mostly unchanged, and improved in few cases. SignificanceIn our cohort, more than half of patients were responders. Psychiatric side effects seem to have been more prevalent compared to other published cohorts. This may be partially explained by a relatively high occurrence of off-target electrodes.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Clinical Characteristics and Seizure Outcomes of Temporal and Extratemporal Lobe Epilepsy Surgery at a Single Center in Cape Town, South Africa
    Asukile, Melody
    Soni, Aayesha J.
    Pan, Eddy Lee
    Eastman, Roland
    Butler, James T.
    Tucker, Lawrence M.
    ANNALS OF NEUROLOGY, 2024, 96 : S184 - S185
  • [42] Multivariate analysis of seizure outcomes after resective surgery for focal epilepsy: a single-center study on 833 patients
    Qiang Meng
    Yong Liu
    Yutao Ren
    Hao Wu
    Jiale Zhang
    Huanfa Li
    Shan Dong
    Jiangpeng Jing
    Xiaofang Liu
    Changwang Du
    Hua Zhang
    Neurosurgical Review, 46
  • [43] Clinical characteristics, late effects and outcomes in pineoblastomas in children: a single center experience
    Gorgun, Omer
    Koc, Basak
    Kebudi, Rejin
    Wolff, Johannes E.
    Kebudi, Abut
    Darendeliler, Emin
    TURKISH JOURNAL OF PEDIATRICS, 2021, 63 (06) : 955 - 961
  • [44] Outcomes of adult patients with type 1 primary refractory acute myeloid leukemia: a single center experience
    Yu, Zhiyou
    Yao, Yao
    Zhang, Yanming
    Chen, Jia
    Xu, Yang
    Xue, Shengli
    Qiu, Huiying
    Tang, Xiaowen
    Han, Yue
    Chen, Suning
    Sun, Aining
    Wu, Depei
    Wang, Ying
    HEMATOLOGY, 2023, 28 (01)
  • [45] Patient selection and outcomes of placement of the Neuropace Responsive Neurostimulator for the treatment of intractable epilepsy: a single center experience
    Agostini, Mark
    Alick, Sasha
    Das, Rohit
    Dave, Hina
    Dieppa, Marisara
    Ding, Kan
    Harvey, Jay
    Hays, Ryan
    Perven, Ghazala
    Lega, Bradley
    Podkorytova, Irina
    Garcia, Rodrigo Zepeda
    Ram, Vijay
    Flay, Joseph
    NEUROLOGY, 2019, 92 (15)
  • [46] Outcomes of children treated for relapsed or refractory acute lymphoblastic leukemia: A single tertiary care center experience
    Almalki, Mosfer
    Abdulatef, Mohammed
    Altrabolsi, Hassan
    Shubayr, Nasser
    CANCER REPORTS, 2024, 7 (07)
  • [47] Long-Term Side Effects of Hematopoietic Stem Cell Transplantation: A Single Center Experience
    Babacan, O.
    Atas, E.
    Eker, I.
    Kesik, V.
    Gursel, O.
    Sarr, E.
    Turker, T.
    Kurekci, A. E.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S423 - S424
  • [48] ACUTE SIDE EFFECTS OF ABDOMINAL RADIATION THERAPY IN WILMS TUMOR- SINGLE CENTER EXPERIENCE
    Khan, M.
    Rashid, A.
    Shahzad, M. K.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 240 - 241
  • [49] Comparison of the side effects of antivirals in chronic hepatitis B patients: a single-center experience
    Sargin, Z. Gok
    Celik, U.
    Dusunceli, I.
    Ustundag, Y.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2022, 85 (04) : 587 - 592
  • [50] Triple therapy in pyridoxine-dependent epilepsy: A single center experience in treatment of 7 patients and evaluation of their outcomes
    Lee, Angela
    Toolan, Elizabeth
    Lobanov, Oleg
    Triplett, Regina
    Grange, Dorothy K.
    Shinawi, Marwan
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (04)